Abstract
The interaction between sparfloxacin (SPFX) and human serum albumin (HSA) had been studied by spectroscopic and molecular modeling methods. The inner filter effect was eliminated to get accurate binding parameters. The site marker competition experiments revealed that SPFX binds to site I (subdomain IIA) of HSA and molecular docking was employed to further define the specific binding sites.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have